ACM
Altium Capital Management Portfolio holdings
AUM
$34.4M
This Quarter Return
+32.4%
1 Year Return
-2.5%
3 Year Return
+357.21%
5 Year Return
–
10 Year Return
–
AUM
$266M
AUM Growth
+$266M
(+12%)
Cap. Flow
+$12.5M
Cap. Flow
% of AUM
4.71%
Top 10 Holdings %
Top 10 Hldgs %
27.06%
Holding
163
New
38
Increased
8
Reduced
20
Closed
28
Top Buys
| 1 |
Akero Therapeutics
AKRO
|
$4.77M |
| 2 |
Pliant Therapeutics
PLRX
|
$4.49M |
| 3 |
BioAtla
BCAB
|
$4.26M |
| 4 |
Rhythm Pharmaceuticals
RYTM
|
$4.17M |
| 5 |
VRNA
Verona Pharma
VRNA
|
$4.13M |
Top Sells
| 1 |
STAAR Surgical
STAA
|
$5.32M |
| 2 |
Esperion Therapeutics
ESPR
|
$3.37M |
| 3 |
DexCom
DXCM
|
$3.28M |
| 4 |
Lantheus
LNTH
|
$3.24M |
| 5 |
LivaNova
LIVN
|
$3.12M |
Sector Composition
| 1 | Healthcare | 81.16% |
| 2 | Financials | 10.35% |
| 3 | Industrials | 0.63% |
| 4 | Consumer Staples | 0.25% |
| 5 | Communication Services | 0.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NSTG
26
DELISTED
NanoString Technologies, Inc.
NSTG
| $3.58M | 1.31% | +280,000 | New | +$3.58M |
|
27
QuidelOrtho
QDEL
$1.95B
| $3.57M | 1.31% | 50,000 | – | – |
|
28
Guardant Health
GH
$8.41B
| $3.55M | 1.3% | 66,000 -39,000 | -37% | -$2.1M |
|
29
Myriad Genetics
MYGN
$593M
| $3.55M | 1.3% | 186,000 -35,000 | -16% | -$668K |
|
30
Inogen
INGN
$216M
| $3.55M | 1.3% | 146,000 -10,000 | -6% | -$243K |
|
|
AKYA
31
DELISTED
Akoya BioSciences
AKYA
| $3.48M | 1.28% | 296,000 | – | – |
|
32
Procept Biorobotics
PRCT
$2.23B
| $3.36M | 1.23% | 81,000 -17,000 | -17% | -$705K |
|
|
EIGR
33
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $3.31M | 1.21% | 440,000 | – | – |
|
34
Keros Therapeutics
KROS
$618M
| $3.31M | 1.21% | 88,000 | – | – |
|
35
Natera
NTRA
$23.1B
| $3.29M | 1.21% | +75,000 | New | +$3.29M |
|
36
Alphatec Holdings
ATEC
$2.35B
| $2.99M | 1.1% | +342,000 | New | +$2.99M |
|
|
NVRO
37
DELISTED
NEVRO CORP.
NVRO
| $2.98M | 1.09% | 64,000 -25,000 | -28% | -$1.16M |
|
|
38
Lantheus
LNTH
$3.73B
| $2.95M | 1.08% | 42,000 -46,000 | -52% | -$3.24M |
|
39
SI-BONE Inc
SIBN
$719M
| $2.92M | 1.07% | +167,000 | New | +$2.92M |
|
40
Verastem
VSTM
$569M
| $2.55M | 0.93% | 3,000,000 | – | – |
|
|
TMPM
41
DELISTED
Turmeric Acquisition Corp. Class A Ordinary Shares
TMPM
| $2.54M | 0.93% | 254,000 | – | – |
|
|
CTIC
42
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $2.49M | 0.91% | +427,000 | New | +$2.49M |
|
43
Avidity Biosciences
RNA
$5.99B
| $2.45M | 0.9% | 150,000 | – | – |
|
44
Twist Bioscience
TWST
$1.63B
| $2.4M | 0.88% | +68,000 | New | +$2.4M |
|
|
SRSA
45
DELISTED
Sarissa Capital Acquisition Corp. Class A Ordinary Shares
SRSA
| $2.25M | 0.82% | 225,000 | – | – |
|
|
ISEE
46
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $2.24M | 0.82% | 125,000 -111,000 | -47% | -$1.99M |
|
47
KORU Medical Systems
KRMD
$195M
| $2.22M | 0.81% | 995,500 | – | – |
|
48
Arcellx
ACLX
$3.85B
| $2.16M | 0.79% | +115,000 | New | +$2.16M |
|
49
Ocular Therapeutix
OCUL
$2.12B
| $2.15M | 0.79% | 517,133 -177,867 | -26% | -$738K |
|
50
Adicet Bio
ACET
$59.9M
| $2.13M | 0.78% | 150,000 | – | – |
|